Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
IACP Member Alert: CBS News Story
Share |

Member Alert

Last evening, CBS News broadcast an investigate report by Jim Axelrod about the telemarketing, compounding, and subsequent billing of pain creams. 

Please click here to view the CBS News story.

Please click here to view an expanded version of the report that aired today on the CBS Morning Show.

IACP STATEMENT ON CBS NEWS REPORT ON PAIN MEDICATION

CBS News has exposed a practice that is in many cases both illegal and unethical: providing medication to an individual in the absence of a relationship with that patient and the patient’s physician. Pharmacists are responsible and obligated to work closely with prescribers and the patients they treat to assure that the right medication is being provided to meet that individual’s health care needs. The violation of that sacred relationship by a marketing firm – especially one that engages in questionable telemarketing practices such as the one identified in this story – is reprehensible and cannot be condoned.

Patients have both a right and a responsibility to have complete information about their medications. That includes not only what the medication is for, how it is supposed to be used, and what questions to ask of their physician and their pharmacist, but also the cost of the medication to both themselves and their employer or insurer. The submission of a bill to any payor – either public or private – must be done in full compliance with the contractual terms between the pharmacy, the patient, and the payor.

Legitimately prescribed and dispensed compounded pain creams and gels bring tremendous relief to those suffering from bone and joint pain. They have the added – and very significant – benefit of being non-addictive. This not only helps patients to enjoy normal activities of daily living, it spares them the destruction of drug addiction. These medications prevent millions of dollars in abused and diverted oral pain medications, and access to pain creams and gels must be maintained. The decision to use a compounded pain cream should only be made based upon a patient’s direct examination by, and consultation with, their physician. 

IACP believes public and private health care payers should aggressively address health care fraud, including taking action against any health care provider that has allegedly broken the law. If a provider has misrepresented what they have dispensed or has not followed law or regulation, they should be held fully accountable.  

IACP AdvanCE Self-paced Webinars Available on Appropriate Marketing

IACP has self-paced webinars available for our members which provide marketing guidelines. Please click here to view our Marketing offerings which include:

FDA & Marketing of Compounds

Grow Your Pharmacy While Remaining Compliant and Avoiding Scrutiny

Growing Your Pharmacy Business Through Sales and Marketing While Avoiding Regulatory Scrutiny

Schemes, Scams and FlimFlams: How the Pharmacy Can Recognize and Avoid Fraud Landmines

In addition, please click here to view, Don’t Mess with Uncle Sam! How the Stark Law and the False Claims Act Impact Pharmacists.

 

What to Do if the Media Calls

If you receive calls from the media, IACP encourages you to direct these press inquiries directly to your Academy's PR Firm, David Ball, Ball Consulting Group, LLC. This media assistance is part of your benefits as an IACP member.

David Ball, Ball Consulting Group, LLC
Office: 617-243-9950
Mobile: 617-548-7809
david@ballcg.com
www.ballcg.com

The International Academy of Compounding Pharmacists (IACP) is an association representing more than 4,000 pharmacists, technicians, students, and members of the compounding community who focus upon the specialty practice of pharmacy compounding. Compounding pharmacists work directly with prescribers including physicians, nurse practitioners and veterinarians to create customized medication solutions for patients and animals whose healthcare needs cannot be met by manufactured medications. More than 150,000 patients and prescribers also belong to our organization via the grassroots advocacy group, Partnership for Personalized Prescriptions (P3). IACP's mission of Protecting, Promoting and Advancing personalized medication solutions is critical for patient healthcare. Visit www.iacprx.org to learn more.
 
IACP is continuing to monitor this situation and will provide updates as available. Please email iacpinfo@iacprx.org with questions regarding this IACP Member Alert.  ​

If you wish to stop receiving email from us, you can simply remove yourself by visiting: @@unsubscribe_url@@

International Academy of Compounding Pharmacists
4638 Riverstone Blvd.
Missouri City, TX 77459

Association Management Software Powered by YourMembership.com®  ::  Legal